CliffBio
small molecule

MINOLIRA

MINOCYCLINE HYDROCHLORIDE

Loss of exclusivityApril 2036latest FDA-listed patent expiry
CompanyEPI HEALTH LLC

Drug detail

Brand nameMINOLIRA
Active ingredientMINOCYCLINE HYDROCHLORIDE
StrengthEQ 135MG BASE
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalMay 2017
Marketing statusDISCN

Listed patents

PatentExpiresType
11103517April 2036product

More from EPI HEALTH LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

MINOLIRA patent cliff — loss of exclusivity April 2036 | CliffBio